# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
CDK statement: 'We are ahead of the anticipated schedule, and as of this morning, substantially all dealer connections are ...
CareMax (NASDAQ:CMAX) reported quarterly earnings of $11.49 per share which beat the analyst consensus estimate of $(8.70) by 2...
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
UBS analyst A.J. Rice maintains CareMax (NASDAQ:CMAX) with a Neutral and lowers the price target from $7 to $6.4.